September is Prostate Cancer Awareness month

Whereas, Prostate cancer constitutes 19% of all cancer diagnoses and 8% of all cancer deaths; and

Whereas, In Ohio an estimated 5,840 new cases of prostate cancer and an estimated 1,020 deaths will occur; and

Whereas, Men with relatives – father, brother, son – with a history of prostate cancer are twice as likely to develop the disease; and

Whereas, Veterans are 1.5 times more likely to get prostate cancer; and

Whereas, Prostate cancer is most commonly diagnosed cancer in American Men and the third leading cause of cancer death behind lung and colon cancer; and

Whereas, this year approximately 161,360 men will be diagnosed with prostate cancer in the United States alone every year – that’s one man every 3.3 minutes and roughly 26,730 die this year from the disease – which is one man every 20 minutes; and

Whereas, 1 in 8 men are diagnosed with prostate cancer. African American men are at the highest risk for the disease with a rate of 1 in 6 men. African American men are 2.3 times more likely to die from the disease: and

Whereas, Education regarding prostate cancer and early detection strategies is critical to saving lives, preserving, and protecting our families; and

Whereas, all men are at risk for prostate cancer and we encourage the citizens of (City) to increase the importance of prostate screenings.


Monday, December 16, 2013

My race car

Mom let me drive my race car! But I have to obey the speed limits and Buckle up! It's the LAW! 

Sunday, December 15, 2013

As Introduced

As Introduced

130th General Assembly
Regular Session
2013-2014
S. C. R. No. 10



Senator Burke 


Cosponsors: Senators Brown, Gardner 



A CONCURRENT RESOLUTION
To memorialize the Congress of the United States to seek the withdrawal of the United States Preventive Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups.


BE IT RESOLVED BY THE SENATE OF THE STATE OF OHIO
(THE HOUSE OF REPRESENTATIVES CONCURRING):


       WHEREAS, The United States Preventive Services Task Force (USPSTF) is an independent panel of nonfederal experts in prevention and evidence-based medicine that is composed of primary care physicians; and

       WHEREAS, The USPSTF members are appointed by the United States Department of Health and Human Services to conduct scientific evidence reviews of a broad range of clinical health care preventive services and develop recommendations for primary care clinicians and health systems; and

       WHEREAS, The USPSTF acknowledges that prostate cancer is the most commonly diagnosed nonskin cancer in men in the United States, with one in six American men being diagnosed with prostate cancer in his lifetime; and

       WHEREAS, Prostate cancer is the second leading cause of cancer-related deaths in men in the United States; and

       WHEREAS, The American Cancer Society estimates that in 2013 approximately 238,590 men in the United States will be diagnosed with prostate cancer and 29,720 men will die from the disease; and

       WHEREAS, In Ohio alone, there are approximately 7,961 newly diagnosed cases of prostate cancer and 1,232 deaths from the disease on an annual basis, according to the February 2011 report issued by the Ohio Cancer Incidence Surveillance System; and

       WHEREAS, In 2008, the USPSTF recommended against prostate-specific antigen-based screening for prostate cancer for men ages 75 and older; and

       WHEREAS, In October 2011, the USPSTF issued a new recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups, because it concluded that there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits; and

       WHEREAS, The USPSTF states that the October 2011 recommendation applies to men in the United States who do not have symptoms of prostate cancer, even though by the time a man experiences symptoms of prostate cancer, the cancer is generally too advanced to cure; and

       WHEREAS, The USPSTF states that its recommendation against screening applies regardless of race, even though the USPSTF acknowledges that African-American men have a substantially higher prostate cancer incidence rate than Caucasian men and more than twice the prostate cancer mortality rate of Caucasian men; and

       WHEREAS, The USPSTF issued this recommendation without having a urologist or oncologist, two types of physicians who specialize in diagnosing and treating patients with prostate cancer, on the task force; and

       WHEREAS, The USPSTF's 2011 recommendation regarding prostate cancer screening follows its recommendation in November 2009 against routine mammograms for women ages 40 to 49 and against teaching women to do breast self-examinations, which Congress rejected after public outcry; and

       WHEREAS, The most recently updated study, the Goteborg Randomized Population-based Prostate Cancer Screening Trial, found that with screening, deaths from prostate cancer dropped 44 per cent over a 14-year period, compared with men who did not undergo screening, and that prostate cancer screening efficiency was similar to other cancers; and

       WHEREAS, The USPSTF recommendation against screening puts into harm's way men who are most at risk: the underinsured, those who live in areas where health care is not readily available, those who have a family history of prostate cancer, and African-American men, who have a higher incidence of and higher mortality rate from prostate cancer than Caucasian men; now therefore be it

       RESOLVED, That we, the members of the 130th General Assembly of the State of Ohio, in adopting this resolution, respectfully memorialize the Congress of the United States to seek the withdrawal of the United States Preventive Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups; and be it further

       RESOLVED, That the Clerk of the Senate transmit duly authenticated copies of this resolution to each member of the Ohio Congressional delegation.

Status Report of Legislation


130th General Assembly - Senate Concurrent Resolutions

Primary Sponsor(s): Burke  

Subject:  Prostate cancer antigen-based screening- withdraw recommendation against




Abbreviations used in the Status Report
A - Amended
P - Postponed
S - Substitute
* - Note

F - Failed to Pass
R - Rereferred
V - Vetoed




Action by Chamber
Senate
House
Introduced

03/19/13

12/10/13


Committee Assigned

Medicaid, Health & Human Services

Health and Aging
Committee Report
11/20/13


Passed 3rd Consideration
12/04/13
Further Action




To Conference Committee




Concurrence


Sent to Governor



End of 10-day period



Governor's Action


Effective Date




As Adopted by the Senate



130th General Assembly
Regular Session
2013-2014
S. C. R. No. 10

Senator Burke 
Cosponsors: Senators Brown, Gardner, Tavares, Bacon, Balderson, Beagle, Coley, Eklund, Faber, Hite, Hughes, Jones, Kearney, LaRose, Lehner, Manning, Obhof, Oelslager, Patton, Peterson, Sawyer, Schaffer, Seitz, Skindell, Smith, Uecker, Widener 


A CONCURRENT RESOLUTION
To memorialize the Congress of the United States to seek the withdrawal of the United States Preventive Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups.


BE IT RESOLVED BY THE SENATE OF THE STATE OF OHIO
(THE HOUSE OF REPRESENTATIVES CONCURRING):
       WHEREAS, The United States Preventive Services Task Force (USPSTF) is an independent panel of nonfederal experts in prevention and evidence-based medicine that is composed of primary care physicians; and

       WHEREAS, The USPSTF members are appointed by the United States Department of Health and Human Services to conduct scientific evidence reviews of a broad range of clinical health care preventive services and develop recommendations for primary care clinicians and health systems; and

       WHEREAS, The USPSTF acknowledges that prostate cancer is the most commonly diagnosed nonskin cancer in men in the United States, with one in six American men being diagnosed with prostate cancer in his lifetime; and

       WHEREAS, Prostate cancer is the second leading cause of cancer-related deaths in men in the United States; and

       WHEREAS, The American Cancer Society estimates that in 2013 approximately 238,590 men in the United States will be diagnosed with prostate cancer and 29,720 men will die from the disease; and

       WHEREAS, In Ohio alone, there are approximately 7,961 newly diagnosed cases of prostate cancer and 1,232 deaths from the disease on an annual basis, according to the February 2011 report issued by the Ohio Cancer Incidence Surveillance System; and

       WHEREAS, In 2008, the USPSTF recommended against prostate-specific antigen-based screening for prostate cancer for men ages 75 and older; and

       WHEREAS, In October 2011, the USPSTF issued a new recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups, because it concluded that there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits; and

       WHEREAS, The USPSTF states that the October 2011 recommendation applies to men in the United States who do not have symptoms of prostate cancer, even though by the time a man experiences symptoms of prostate cancer, the cancer is generally too advanced to cure; and

       WHEREAS, The USPSTF states that its recommendation against screening applies regardless of race, even though the USPSTF acknowledges that African-American men have a substantially higher prostate cancer incidence rate than Caucasian men and more than twice the prostate cancer mortality rate of Caucasian men; and

       WHEREAS, The USPSTF issued this recommendation without having a urologist or oncologist, two types of physicians who specialize in diagnosing and treating patients with prostate cancer, on the task force; and

       WHEREAS, The USPSTF's 2011 recommendation regarding prostate cancer screening follows its recommendation in November 2009 against routine mammograms for women ages 40 to 49 and against teaching women to do breast self-examinations, which Congress rejected after public outcry; and

       WHEREAS, The most recently updated study, the Goteborg Randomized Population-based Prostate Cancer Screening Trial, found that with screening, deaths from prostate cancer dropped 44 per cent over a 14-year period, compared with men who did not undergo screening, and that prostate cancer screening efficiency was similar to other cancers; and

       WHEREAS, The USPSTF recommendation against screening puts into harm's way men who are most at risk: the underinsured, those who live in areas where health care is not readily available, those who have a family history of prostate cancer, and African-American men, who have a higher incidence of and higher mortality rate from prostate cancer than Caucasian men; now therefore be it

       RESOLVED, That we, the members of the 130th General Assembly of the State of Ohio, in adopting this resolution, respectfully memorialize the Congress of the United States to seek the withdrawal of the United States Preventive Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups; and be it further

       RESOLVED, That the Clerk of the Senate transmit duly authenticated copies of this resolution to each member of the Ohio Congressional delegation.

Sunday, December 1, 2013

National Shave Day

Today is December 1st also National Shave Day.

On Movember 1st men quit shaving for the whole month in support of Prostate Cancer Awareness. Today we were at The Old Familiar Barbershop they were giving out FREE shaves and a razor!
National Shave Day 2013